Status:
COMPLETED
Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I
Lead Sponsor:
Fenway Community Health
Collaborating Sponsors:
Massachusetts General Hospital
Boston Children's Hospital
Conditions:
HIV Infection
Eligibility:
All Genders
13-24 years
Brief Summary
HIV is increasing among adolescents and young adults in the US. Antiretroviral medications, when taken correctly (≥90% of prescribed doses taken), can vastly improve life expectancy. However, adherenc...
Detailed Description
This phase of the protocol focuses on setting up the infrastructure necessary for conducting the study, including hiring and training activities with study staff. This time will be spent conducting in...
Eligibility Criteria
Inclusion
- Phase I
- Age 13 to 24 years
- HIV-infected and aware of HIV-infection status
- Currently taking antiretroviral therapy, has been prescribed antiretroviral therapy in the past 6 months, or a medical provider has recommended antiretroviral medications within the last 6 months
- Willing and able to provide informed consent or assent (if under the age of 18)
Exclusion
- Not willing or able to provide informed consent or assent (if under the age of 18)
- Is dealing with a severe mental illness requiring immediate treatment (e.g. active psychotic episode) or a mental illness that would limit a participant's ability to engage with study protocol (e.g. dementia)
- Has severe cognitive limitations that would limit a participant's ability to comprehend the informed consent or assent.
- Phase II
- Inclusion Criteria:
- Age 13-24 years
- HIV-infected and aware of HIV-infection status
- Currently taking antiretroviral therapy
- Self-reported difficulties adhering to HIV medications in the past 3 months
- Self-identify as heterosexual or LGB
- Willing and able to provide informed consent/consent of parent/guardian if under the age of 18
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 6 2013
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01253850
Start Date
August 1 2010
End Date
March 6 2013
Last Update
April 17 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Children's Hospital Boston
Boston, Massachusetts, United States, 02115
3
Fenway Community Health
Boston, Massachusetts, United States, 02215